Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;20(5):448.
doi: 10.7861/clinmed.rib.20.5.1.

Research in brief: Serum urate reduction and its effect on the progression of chronic kidney disease

Rajan S Pooni  1 , Richard Corbett  2
Affiliations
Comment

Research in brief: Serum urate reduction and its effect on the progression of chronic kidney disease

Rajan S Pooni et al. Clin Med (Lond). 2020 Sep.
No abstract available

PubMed Disclaimer

Comment on

  • Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M; PERL Study Group. Doria A, et al. N Engl J Med. 2020 Jun 25;382(26):2493-2503. doi: 10.1056/NEJMoa1916624. N Engl J Med. 2020. PMID: 32579810 Free PMC article. Clinical Trial.
  • Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW; CKD-FIX Study Investigators. Badve SV, et al. N Engl J Med. 2020 Jun 25;382(26):2504-2513. doi: 10.1056/NEJMoa1915833. N Engl J Med. 2020. PMID: 32579811 Clinical Trial.

References

    1. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006;332:563–4. - PMC - PubMed
    1. Insight Health Economics Chronic kidney disease in England: The human and financial cost. NHS Kidney Care, 2012
    1. Jalal DI, Chonchol M, Chen W, Targher G. Uric acid as a target of therapy in CKD. Am J Kidney Dis 2013;61:134–46. - PMC - PubMed
    1. Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008;19:1204–11. - PMC - PubMed
    1. Mauer M, Doria A. Uric acid and diabetic nephropathy risk. Contrib Nephrol 2018;192:103–9. - PMC - PubMed